Novartis Poised for Growth as CEO Hands Baton to Successor Post author:Sam Post published:January 23, 2018 Post category:BioPharma Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace You Might Also Like Alnylam Stock Catapults as Genetic Disease Drug Meets All Phase III Goals September 19, 2017 Meet 7 Bay Area Scientists Changing the Face of Biotech June 8, 2017 Japan's Astellas Pays $102.5M for U.S. Biotech Universal Cells February 13, 2018
